SEPTInvestingStart Free

BBOT 10-Q: SEC filing

BridgeBio Oncology Therapeutics

Filed with the SEC on · accession 0001193125-26-455521

BBOT filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -4.3% by the first close after the filing.

Summary of the filing

BridgeBio Oncology Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, fair value measurements, and related party transactions.

For details, click here →How to read a 10-Q →

Key details

FilerBridgeBio Oncology Therapeutics, Inc.
Related partyBridgeBio Pharma
License and crada counterpartyLeidos Biomedical Research, Inc.
License and crada counterpartyLawrence Livermore National Security, LLC
License agreement counterpartyUniversity of California

How BBOT stock reacted

Close before

$2.30

Nov 9, 2026

First close after

-4.35%

$2.20

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BBOT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BBOT?

Click here

Frequently asked questions

What did BBOT file with the SEC on Nov 10, 2026?

BBOT filed a 10-Q (SEC filing). BridgeBio Oncology Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, fair value measurements, and related party transactions.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did BBOT stock react to this filing?

BBOT closed at $2.30 before the filing and $2.20 on Nov 10, 2026 (-4.35%).

Other BBOT SEC filings

Get alerts when BBOT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BBOT overviewBBOT analysisBBOT newsLatest SEC filings